AMY JENSEN

HR 1707 Grown in America Act

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

Value-based care, Medicare Advantage

Value-based care and value of integrated delivery systems; appropriate use of AI in health care; workforce issues; affordability issues

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D, MFN U.S. Competitiveness issues

Health care access and affordability, delivery system reforms, and patient-first care.

Health care affordability, delivery system reforms, and patient-first care.

Value of prescription drugs and patient access Issues related to Medicare Parts B & D, MFN Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines Health care workforce Clinical Trial Modernization Act

Physician payment issues, including Patients First Act (H.R.9693); access to primary care; ECAPS Act; health care access and affordability issues

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; U.S. Competitiveness

FDA modernization

Chronic kidney disease issues; upstream kidney disease prevention; S.1552, Living Donor Protection Act; access to innovation for kidney patients

rural health access; health care affordability; Medicare physician payment; transparency

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; S 2355, Patients Deserve Price Tags

Role of molecular profiling in cancer care; access to molecular profiling technologies in Medicare; prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing.

Medicare NCD on access to power standing systems; Prior authorization reforms to speed access for people with serious disabilities; HR 5081, DMEPOS Relief Act of 2025; HR 1703/S247 Choices for Increased Mobility Act of 2025

HR 8871, DME Scammer Prevention Act; Proactive Solutions to Address Waste, Fraud and Abuse; Comprehensive Regulations to Uncover Suspicious Healthcare-CRUSH RFI (CMS-6098-NC)

Implementation of HR 4993 the Joe Fiandra Access to Home Infusion Act, including issues in CMS-1828-P; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines

Preserving US competitiveness and patient access to lifesaving medicines, especially for treatment of rare diseases

Value of Medicaid to health center patients; Importance of Medicare and Medicaid PPS to provide access for health center patients.

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Telehealth extension and issues impacting health centers; Importance of nutrition support and behavioral health and substance abuse services to patients; HR 9389, Nutrition Education and Chronic Disease Prevention in Community Health Centers; HR 8201, Expanding Community Access to Health Services Act

Health care affordability, delivery system reforms, and patient-first care.

Health care access and affordability, delivery system reforms, and patient-first care.

Value-based care; appropriate use of AI in health care; workforce issues; affordability issues

Value-based care, Medicare Advantage

Value of prescription drugs and patient access Issues related to Medicare Parts B & D, MFN Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Physician payment issues, including Patients First Act (H.R.9693); access to primary care; ECAPS Act; health care access and affordability issues

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; P.L. 119-21; U.S. Competitiveness

Chronic kidney disease issues; upstream kidney disease prevention; S.1552, Living Donor Protection Act; access to innovation for kidney patients

rural health access; health care affordability; Medicare physician payment

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D, MFN U.S. Competitiveness issues

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing; HR 5269 RESULTS Act; HR 7148 the Consolidated Appropriations Act of 2026; updated timing of reporting under PAMA

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools

Health care affordability, delivery system reforms, and patient-first care.

Health care access and affordability, delivery system reforms, and patient-first care.

HR 4993 the Joe Fiandra Access to Home Infusion Act; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines; HR 7148 the Consolidated Appropriations Act of 2026

S 932/HR 1262 Mikaela Naylon Give Kids a Chance Act of 2025; Preserving US competitiveness and patient access to lifesaving medicines; HR 7148 the Consolidated Appropriations Act of 2026

Value of Medicaid to health center patients; Importance of Medicare and Medicaid PPS to provide access for health center patients.

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients, Telehealth extension and issues impacting health centers; HR 7148 the Consolidated Appropriations Act of 2026; importance of nutrition support and behavioral health and substance abuse services to patients.

Medicare NCD on access to power standing systems; Prior authorization reforms to speed access for people with serious disabilities; Service and repair reforms in health programs; HR 5081, DMEPOS Relief Act of 2025; HR 1703 Choices for Increased Mobility Act of 2025

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act

rural health access; extensions of telehealth waivers and acute hospital care at home waiver program; H.R.7148, Consolidated Appropriations Act of 2026; health care affordability

Value-based care, Medicare Advantage

Value-based care; appropriate use of AI in health care; workforce issues; affordability issues

Physician payment issues; telehealth issues; access to primary care; expiring health provisions, H.R. 7148, Consolidated Appropriations Act, 2026

Expiring public health provisions, including teaching health center graduate medical education, H.R. 7148, Consolidated Appropriations Act, 2026

Value of prescription drugs and patient access Issues related to Medicare Parts B & D, MFN Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D, MFN U.S. Competitiveness issues

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; P.L. 119-21; U.S. Competitiveness

Chronic kidney disease issues; upstream kidney disease prevention; S.1552, Living Donor Protection Act

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237); Telehealth Modernization Act of 2025 (H.R. 5081/S. 2709); H.R. 7148, Consolidated Appropriations Act, 2026

Health care access and affordability; delivery system reform; and patient-first care.

Health care access and affordability; delivery system reform; and patient-first care.

HR 4993 the Joe Fiandra Access to Home Infusion Act; Promoting US competitiveness while ensuring continued patient access to lifesaving medicines

S 932/HR 1262 Mikaela Naylon Give Kids a Chance Act of 2025; Preserving US competitiveness and patient access to lifesaving medicines

Physician payment issues; telehealth issues; access to primary care; P.L. 119-21; expiring health provisions, including H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, P.L. 119-44; affordability issues; expiring public health provisions, including H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; HR 5081, Telehealth Modernization Act, prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing; HR 5269 RESULTS Act

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025/Public Law No: 119-44 Promoting U.S. competitiveness while ensuring U.S. leadership role in developing medicines

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients, Telehealth extension and issues impacting health centers

Value of Medicaid to health center patients; HR 5081, Telehealth Modernization Act; payment parity in telehealth for health centers

Value-based care; appropriate use of AI in health care; workforce issues; affordability issues

Value-based care, Medicare Advantage

Medicare NCD on access to power standing systems; Prior authorization reforms to speed access for people with serious disabilities; Service and repair reforms in health programs; HR 5081, Telehealth Modernization Act; HR 2005, DMEPOS Relief Act of 2025; HR 1703 Choices for Increased Mobility Act of 2025

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237); Telehealth Modernization Act of 2025 (H.R. 5081/S. 2709); H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 U.S. Competitiveness issues

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946/S. 1862, ORPHAN Cures Act; P.L. 119-21; U.S. Competitiveness

Chronic kidney disease issues; upstream kidney disease prevention; living donor protection issues

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.2483, the Support for Patients and Communities Reauthorization Act)

rural health access; extensions of telehealth waivers and acute hospital care at home waiver program; health care affordability

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients; HR 2483 the SUPPORT Act

Value of Medicaid to health center patients; HR 1 (Public law 119-21); HR 5081, Telehealth Modernization Act

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; HR 5081, Telehealth Modernization Act, prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests

HR 1 (Public Law 119-21) Reforms to Medicaid and health programs to ensure severely disabled can access; Medicare NCD on access to power standing systems; Prior authorization reforms to speed access for people with serious disabilities; Service and repair reforms in health programs; HR 5081, Telehealth Modernization Act; Competitive bidding reform proposals impacting access for people with severe disabilities

HR 4993 the Joe Fiandra Access to Home Infusion Act

Priority Review Voucher extension; S 932/HR 1262 Give Kids a Chance Act of 2025; S 1862/HR 946 Orphan Cures Act; Importance of patient access to treatments in HR 1 (Public Law 119-21)

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT Act

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - the Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

Differentiate beer from hemp; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act; Proposals to extend and change the Tax Cuts and Jobs Act (PL 119-21)

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946/S. 1862, ORPHAN Cures Act; P.L. 119-21

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.2483, the Support for Patients and Communities Reauthorization Act)

rural health access; extensions of telehealth waivers and acute hospital care at home waiver program; health care affordability

Chronic kidney disease issues; upstream kidney disease prevention

Physician payment issues; telehealth; access to primary care; P.L. 119-21; expiring health provisions

H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025

Value-based care; appropriate use of AI in health care; workforce issues

Value-based care, Medicare Advantage

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237); Telehealth Modernization Act of 2025 (H.R. 5081/S. 2709)

Value-based care; appropriate use of AI in health care

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R. 4313/S. 2237)

Value of prescription drugs and patient access Issues related to Medicare Parts B & D P.L. 119-21 H.R. 946/S. 1862, ORPHAN Cures Act H.R. 2483, SUPPORT Act

Physician payment issues; telehealth; access to primary care; P.L. 119-21

H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025

Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 H.R.946/S.1862 - ORPHAN Cures Act

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946/S. 1862, ORPHAN Cures Act; P.L. 119-21

Chronic kidney disease issues; P.L. 119-21

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.2483, the Support for Patients and Communities Reauthorization Act); rural health access; telehealth; P.L. 119-21

Joe Fiandra Access to Home Infusion

Priority Review Voucher extension; S 932/HR 1262 Give Kids a Chance Act of 2025; S 1862/HR 946 Orphan Cures Act; Importance of patient access to treatments in HR 1 (Public Law 119-21)

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests

Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients; HR 2483 the SUPPORT Act

Value of Medicaid to health center patients; HR 1 (Public law 119-21)

HR 1 (Public Law 119-21) Reforms to Medicaid and health programs to ensure severely disabled can access; Medicare NCD on access to power standing systems; Prior authorization reforms to speed access for people with serious disabilities; Service and repair reforms in health programs

Differentiate beer from cannabis; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act; Proposals to extend and change the Tax Cuts and Jobs Act (PL 119-21)

HR 1703 Payment for manual mobility devices under Part B of the Medicare program; HR 1968 the Full Year Continuing Appropriations and Extensions Act of 2025

HR 1968 the Full Year Continuing Appropriations and Extensions Act of 2025; Extending Community Health Center, Teaching Health Center and National Health Service Corps funding. Value of Medicaid to health center patients

Value of Medicaid to health center patients

Joe Fiandra Access to Home Infusion

Priority Review Voucher extension; S 932 Give Kids a Chance Act of 2025

Update National Coverage Determination (NCD) on Next Generation Sequencing 90.2

Differentiate beer from cannabis; general policy regarding the regulation of the alcohol industry.

HR 1707 Grown in America Act

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R.8260/S.4350 from 118th Congress); H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

H.R.2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

Physician payment, health care workforce and training, and telehealth issues (H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025)

H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; H.R. 1672, Maintaining Investments in New Innovation Act; H.R. 946, ORPHAN Cures Act

Chronic kidney disease issues

General health care issues related to behavioral health and integration with primary care and addressing the opioid epidemic (including H.R.4531/S.3393, the Support for Patients and Communities Reauthorization Act); health care workforce improvements; public health improvements; H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025.

Value-based care issues; physician workforce issues

Value-based care issues; physician workforce issues

HR 5397 the Joe Fiandra Access to Home Infusion Act, HR 5526 Seniors' Access to Critical Medications Act; HR 8816 American Medical Innovation and Investment Act; Issues related to patient access to rare disease therapies

Extension of Priority Review Vouchers in S 4583; HR 7384 the Creating Hope Reauthorization Act, FDA reforms to improve rare disease patient perspective input and flexibilities

Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R.8260/S.4350); AINS to H.R.7623, the Telehealth Modernization Act; AINS to H.R.8261, the Preserving Telehealth, Hospital, and Ambulance Access Act.

Differentiate beer from cannabis; general policy regarding the regulation of the alcohol industry

Improve integration of behavioral health and primary care; advance value-based care; address workforce shortages and improve data collection under Graduate Medical Education program; adequate physician reimbursement; issues related to Centers for Medicare and Medicaid Innovation; H.R.7623 Telehealth Modernization Act

Value of prescription drugs and patient access Issues related to Medicare Parts B & D Implementation of P.L. 117-659 (H.R.5376) - Inflation Reduction Act

RNA interference scientific advancements and rare diseases; differentiation of genetically-targeted therapies; S.476/H.R.5547, Maintaining Investments in New Innovation Act; patient access to appropriate home infusion (H.R. 5397, Joe Fiandra Access to Home Infusion Act; AINS to H.R. 8816; AINS to H.R. 5526)

Access to preventative health; HR 5378 The Lower Costs, More Transparency Act to extend funding for Community Health Centers, Teaching Health Centers GME and the National Health Service Corps; Bipartisan Primary Care and Health Workforce Act; S 2840 the Primary Care and Health Workforce Act; and other workforce improvements; HR 7623 the Telehealth Modernization Act

Extending funding for Community Health Centers and preserving and enhancing federal reimbursement methodologies; ensuring continued access to telehealth services; HR 7623 Telehealth Modernization Act; Medicare National Coverage Determination on HIV Pre-exposure Prophylaxis (PrEP)

Value of coordination and management in providing high quality, efficient health care coverage